![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Rifabutin (RBT) Decreases Cabotegravir (CAB) Exposure Following Oral Co-administration
|
|
|
Reported by Jules Levin
19th International Workshop on Clinical
Pharmacology of Antiviral Therapy 2018
Baltimore, MD, USA
22-24 May 2018
S Ford,1 Y Lou,2 N Lewis,3 R D'Amico,4 W Spreen,4 P Patel4
1GlaxoSmithKline, Research Triangle Park, NC; 2Parexel International, Research Triangle Park, NC; 3GlaxoSmithKline, UP, PA; 4ViiV Healthcare, Research Triangle Park, NC
![0529181](../images%20/052818/052818-4/0529181.gif)
![0529182](../images%20/052818/052818-4/0529182.gif)
![0529183](../images%20/052818/052818-4/0529183.gif)
![0529184](../images%20/052818/052818-4/0529184.gif)
![0529185](../images%20/052818/052818-4/0529185.gif)
![0529186](../images%20/052818/052818-4/0529186.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|